SOFIE Co. dba SOFIE

FDA inspection history in Totowa, New Jersey, 2023

1
Form 483

Every document, by year

  • Form 483

2023: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2023One Form 483, at Totowa, New Jersey.

Cited most

Across all SOFIE Co. dba SOFIE observations on file

  • 21 CFR 212.100(b)
    What do I do if I receive a complaint about a PET drug product produced at my facility?
    1
  • 21 CFR 212.30(a)
    What requirements must my facilities and equipment meet?
    1
  • 21 CFR 212.71(b)
    What actions must I take if a batch of PET drug product does not conform to specifications?
    1
  • 21 CFR 212.80(d)
    What are the requirements associated with labeling and packaging PET drug products?
    1

The complete SOFIE Co. dba SOFIE file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2023-08-11483 Form 483$99

Investigators on these documents

Cadre X. Bees (1)

FEI number 3008415560 · most recent document Aug 11, 2023

About SOFIE Co. dba SOFIE

How many FDA Form 483s has SOFIE Co. dba SOFIE received?

FDA Intel has 1 Form 483 on file for SOFIE Co. dba SOFIE; the most recent is dated Aug 11, 2023.

When was SOFIE Co. dba SOFIE last inspected by FDA?

The most recent FDA inspection document on file for SOFIE Co. dba SOFIE is a Form 483 dated Aug 11, 2023, for the site in Totowa, New Jersey.

What did FDA cite at SOFIE Co. dba SOFIE?

The regulations cited most in the observations on file for SOFIE Co. dba SOFIE are 21 CFR 212.100(b) (What do I do if I receive a complaint about a PET drug product produced at my facility?), 1 time; 21 CFR 212.30(a) (What requirements must my facilities and equipment meet?), 1 time; 21 CFR 212.71(b) (What actions must I take if a batch of PET drug product does not conform to specifications?), 1 time.